Archives: Speakers

Jae-Hyun (Jay) Park is a new drug developer, Ph.D., and a Korean pharmacist. He has experience in research institutes and strategic planning teams of large Korean pharmaceutical companies and start-ups. Jay has expertise in various fields such as non-clinical research, patents, and technology licensing. Currently, he is developing a new drug to treat COVID19 using natural substances.

Dr. Kumar Gaurav is presently working as Director & Cluster Head, Medical Affairs in Dr Reddys Lab ,Hyderabad

Kumar has 12+ years of Medical affairs experience including clinical experience across diversified sectors in Pharma Industry, health care and devices.In his previous roles,Kumar was with Allergan wherein he was Head-Medical Affairs, South Asia and Global Lead for Movement Disorders. Prior to Allergen he has worked with Baxter, Astra Zeneca and Ranbaxy in Medical Affairs & Clinical Research. He has a hands on experience in managing teams and handled therapy areas including Urology, Neurosciences, Devices, Anaesthesia, Critical care, Cardio-vascular, Metabolic & Anti-infectives.

In his career of over 12+ years in pharma industry,Kumar was responsible for developing & executing Medical strategy,including flagship medical education programs, digital initiatives, consensus statements, global advisory board meetings for LCM and global evidence generation projects including optimal support in investigator initiated studies with a focus on treatment paradigms, and strategies for overcoming barriers to access and optimization of patient outcomes.

Kumar has been significantly involved in building thought leader (TL) advocacy across organizations in India and Global regions and also in developing processes for facilitating the same.  He has been involved in launch excellence with numerous successful launches to his credit in Cardiovascular and Neurology space-Crestor,Seloken XL,Plasmalyte ,Indications expansion of Botox therapuetics etc.He is also credited with successfully establishing & driving the Field Based Medical Affairs (MSL) Excellence in all organisations he worked with.

As a part of his responsibility as a Clinical Research Team Lead, he was responsible for preparing clinical development plans for various NCEs – study designs and study conduct plans especially early phase studies and atypical generics. Overseeing the preparation and timely, quality delivery of Clinical Study Protocols, Clinical Study Reports for BE studies as well as phase I to IV clinical trials, for multi centric global clinical trials across various therapeutic areas, preparation of Clinical Overviews, Feasibility reports, Safety reports, PSURs. Faced International Regulatory Audits from various regions as ANVISA, USFDA, .DCGI and providing medical support for regulatory activities.

An experienced medical writer, Kumar has over 20+ publications to his credit in various National & International Journals of repute including a book Chapter

Kumar has done his MBBS from MGR University Chennai and his MD in Pharmacology & Therapeutics from Banaras Hindu University, Varanasi.

Donna Fraser, Therapeutic Strategy Director, US based.
25 years in Industry with the past 18 years at Novotech.
Donna is a NZ Comprehensive Registered Nurse with a clinical background in Nursing, Certified Medical Case Management, Project Management and Clinical Operations.
As Director of Therapeutic Strategy, Donna partners with the Novotech Business Development team to provide strategic oversight across an extensive range of therapeutic areas by leveraging her clinical experience, investigator site relationships and specialist knowledge.
Established in 1997, Novotech is a global CRO recognized for its partnership with Sponsors clinical trial development and management.
With its presence in 34 office locations and a dedicated team of 3,000+ professionals worldwide. Novotech supports clinical trials across Asia Pacific, United States and Europe.
www.novotech-cro.com

Chris Kim received his medical degree from the Perelman School of Medicine at the University of Pennsylvania and has been in medical device research and development for 15 years. He currently teaches at two medical schools in the Philadelphia area on best research practices while working as the VP of Clinical Research and Human Factors at Schlesinger Group.

Chris has worked on over 300 different medical devices over the course of his career (ranging from scalpels to phone applications) and is a trusted source of regulatory knowledge in the area of human factors both for the U.S. and  outside of the U.S.

Brendan is a specialist in financial planning (how people should use their money) and behavioural finance (how people actually use their money), and uses these skillsets to manage one of the fastest growing, and most innovative B2B robo advisors in the world.

Simon is a Manager at KPMG Financial Services and specializes in the transformations, redesigns and growth projects of automotive banks and captives, as well as the development of digital leasing business models.

Zaliia is the Head of Business Development at Kidbrooke, a WealthTech API-provider empowering the industry with cutting-edge financial analytics. Driven by a passion for technology and finance, she believes that digital innovation can upgrade the wealth management sector to the next, more engaging, transparent and comprehensive level. Zaliia holds another position as a Vice-Chairwoman at the Nordic RegTech Association.